Turning the Tide Against HIV and Tuberculosis

Global Fund Investment Guidance for Eastern Europe and Central Asia

The Global Fund’s vision for the Eastern Europe and Central Asia region is to stabilize HIV incidence and contain the spread of drug-resistant TB.

For the allocation period of 2014-2016 and the implementation covering 2014-20176, the Global Fund is aiming to contribute to the following goals:

  • To reduce HIV transmission among people who inject drugs by 50%.
  • To increase to and sustain coverage of 80% of those in need of antiretroviral (ARV) therapy.
  • To diagnose at least 85% of TB patients, especially multidrug/extensively drug-resistant-TB patients.
  • To successfully treat at least 90% of patients with drugsensitive TB and at least 75% of patients notified as having multidrug-resistant TB.

Below you can see a more detailed description of the objectives and the differentiated approach, sustainability and co-financing targets.Screen Shot 2016-03-14 at 9.08.58 PM

Screen Shot 2016-03-14 at 9.09.29 PM

Here you can also view and download the full text of the guidance.